These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 665309)

  • 41. Blood pressure, body fluid volumes and glomerular filtration rate during treatment with labetalol in essential hypertension.
    Rasmussen S; Nielsen PE
    Br J Clin Pharmacol; 1981 Sep; 12(3):349-53. PubMed ID: 7295465
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Treatment of arterial hypertension with propranolol].
    Cristodorescu R; Costea M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1977; 29(1):17-24. PubMed ID: 16326
    [No Abstract]   [Full Text] [Related]  

  • 43. Long term propranolol and hydralazine in hypertension.
    Pandit RB
    J Assoc Physicians India; 1984 Feb; 32(2):199-202. PubMed ID: 6430870
    [No Abstract]   [Full Text] [Related]  

  • 44. Beta-blocking therapy: Propranolol.
    Pettinger WA
    Postgrad Med; 1974 Oct; 56(5):68-73. PubMed ID: 4412183
    [No Abstract]   [Full Text] [Related]  

  • 45. Treatment of hypertension with propranolol and hydralazine.
    Hansson L; Olander R; Aberg H; Malmcrona R; Westerlund A
    Acta Med Scand; 1971 Dec; 190(6):531-4. PubMed ID: 5149097
    [No Abstract]   [Full Text] [Related]  

  • 46. Blood pressure, plasma volume, extracellular volume and glomerular filtration rate during treatment with labetalol in essential hypertension.
    Rasmussen S; Nielsen PE
    Postgrad Med J; 1980; 56 Suppl 2():33-6. PubMed ID: 7433340
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combined treatment of hypertension with vasodilatation and beta-adrenergic blockade.
    Hansson L; Zweifler AJ
    Mich Med; 1973 Oct; 72(30):695-8. PubMed ID: 4147721
    [No Abstract]   [Full Text] [Related]  

  • 48. [Treatment of essential hypertension with a combination of propranolol, spironolactone-thiabutazide and dihydralazine (author's transl)].
    Ebel H; Lübke H; Klaus D; Zehner J; Witzgall H
    Dtsch Med Wochenschr; 1978 Oct; 103(42):1650-5. PubMed ID: 699788
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Propranolol-induced hallucinosis.
    Horn JR; Rylander ML; Hicks HM
    Clin Pharm; 1982; 1(5):464-8. PubMed ID: 7184681
    [No Abstract]   [Full Text] [Related]  

  • 50. Serial measurements of systolic time intervals: effects of propranolol alone and combined with other agents in hypertensive patients.
    Kyle MC; Freis ED
    Hypertension; 1980; 2(1):111-7. PubMed ID: 7372352
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Captopril in treatment-resistant hypertension (author's transl)].
    Studer A; Lüscher T; Siegenthaler W; Vetter W
    Schweiz Med Wochenschr; 1980 Dec; 110(51):1987-91. PubMed ID: 7025191
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Cross-over trial with Peripress (prazosin) and Apresolin (hydralazin), both in combination with beta-blocker].
    Melkild A
    Tidsskr Nor Laegeforen; 1980 Jan; 100(3):148-49. PubMed ID: 6992338
    [No Abstract]   [Full Text] [Related]  

  • 53. [Treatment of hypertension with obsilazin].
    Sirakova V; Penkov N; Kaponov Kh; Dimitrov G
    Vutr Boles; 1986; 25(2):32-6. PubMed ID: 2872755
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Propranolol therapy in hypertension].
    Krediet RT
    Ned Tijdschr Geneeskd; 1978 May; 122(21):761-5. PubMed ID: 349413
    [No Abstract]   [Full Text] [Related]  

  • 55. The comeback of hydralazine.
    Koch-Weser J
    Am Heart J; 1978 Jan; 95(1):1-3. PubMed ID: 619579
    [No Abstract]   [Full Text] [Related]  

  • 56. The addition of prazosin to standard triple therapy in the treatment of severe hypertension.
    Heagerty AM; Russell GI; Bing RF; Thurston H; Swales JD
    Br J Clin Pharmacol; 1982 Apr; 13(4):539-41. PubMed ID: 7066169
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Decreased renal plasma flow during propranolol treatment in essential hypertension.
    Falch DK; Odegaard AE; Norman N
    Acta Med Scand; 1979; 205(1-2):91-5. PubMed ID: 760408
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Minoxidil in refractory hypertension. Effects on blood pressure, plasma volume and muscle blood flow.
    Andersson O; Sivertsson R
    Acta Med Scand; 1979; 205(3):213-9. PubMed ID: 34316
    [No Abstract]   [Full Text] [Related]  

  • 59. Changes in plasma and extracellular fluid volumes in patients with essential hypertension during long-term treatment with hydrochlorothiazide.
    Leth A
    Circulation; 1970 Sep; 42(3):479-85. PubMed ID: 4988973
    [No Abstract]   [Full Text] [Related]  

  • 60. Hydralazine in arterial hypertension. Randomized double-blind comparison of conventional/Slow-Release formulation and of b.i.d./q.i.d. dosage regimens.
    Wulff K; Lenz K; Krogsgaard AR; Holst B
    Acta Med Scand; 1980; 208(1-2):49-54. PubMed ID: 7435247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.